中医药综合疗法对急性脑梗死患者超敏C-反应蛋白的影响  

The impact of combination therapy of TCM on acute cerebral infarction ultra-sensitivity C-reactive protein

作　　者：吴艳华[1] 温伟伦[1] 王海红[1] 吴笛[1] 

机构地区：[1]暨南大学第四附属医院广州市红十字会医院,广东广州510220

出　　处：《中医临床研究》2011年第17期12-13,共2页Clinical Journal Of Chinese Medicine

基　　金：广东省科技计划项目(2006B35630004)

摘　　要：目的:观察中医药综合疗法对急性脑梗死患者超敏C-反应蛋白的影响,探讨其疗效机制。方法:将108例急性脑梗死患者,随机分为中医药综合疗法组、灯盏花素针配合光量子液疗组和灯盏花素针组各36例,三组疗程均为14d。观察治疗前后三组的血清Hs-CRP的变化。结果:中医药综合疗法组和灯盏花素针配合光量子液疗组血清Hs-CRP水平明显降低,优于灯盏花素针组。结论:中医药综合疗法能降低急性脑梗死血清Hs-CRP水平,推测其疗效机制可能与减轻脑缺血后炎症损伤有关。Objective：To observe The impact of combination therapy of TCM on acute cerebral infarction ultra-sensitivity C-reactive protein,then to explore its efficacy mechanism.Methods：108 cases of acute cerebral infarction were randomly divided into TCM combination therapy group,breviscapine needle with quantum fluid therapy group and breviscapine acupuncture group,for 36 cases in each,14 days as a course,then observed the change of three groups of serum Hs-CRP before and after the treatment.Results：Hs-CRP serum levels were significantly lower after compared TCM combination therapy group and breviscapine needle with quantum fluid therapy group,which was better than breviscapine acupuncture group.Conclusion：Combination therapy of TCM could lower acute cerebral infarction serum Hs-CRP levels,so we speculate its efficacy mechanism may have relation with reduce inflammatory injury after cerebral ischemia.

关 键 词：急性脑梗死 中医药综合疗法 超敏C-反应蛋白 

分 类 号：R743.33[医药卫生—神经病学与精神病学]